Your session is about to expire
← Back to Search
Amino Acid
Dietary Supplement for Osteoarthritis
N/A
Waitlist Available
Led By Guangju Zhai, PhD
Research Sponsored by Memorial University of Newfoundland
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Must be ambulatory
Be older than 18 years old
Must not have
Use of Intra-articular viscosupplementation or platelet rich plasma at any point
Use of bisphosphonates within 2 years
Timeline
Screening 3 weeks
Treatment Varies
Follow Up up to 20 months
Awards & highlights
No Placebo-Only Group
Summary
This trial will test whether or not arginine can help with osteoarthritis by looking at cartilage health and participant symptoms.
Who is the study for?
This trial is for adults with primary knee osteoarthritis who are scheduled for knee replacement surgery within the next 6 months, can walk on their own, and live near St. John's in Canada. It excludes those with other types of arthritis or recent treatments/supplements that could affect results.
What is being tested?
The study tests if taking arginine supplements affects osteoarthritis progression. Participants will be split into two groups: one taking arginine and the other not taking anything. Their joint health will be monitored through lab tests and questionnaires.
What are the potential side effects?
While specific side effects aren't listed, dietary supplements like arginine may cause gastrointestinal discomfort, allergies, changes in blood pressure, or interact with certain medications.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowSelect...
I can walk on my own.
Exclusion Criteria
You may be eligible for the trial if you check “No” for criteria below:Select...
I have received treatments like viscosupplementation or PRP injections.
Select...
I have used bisphosphonates in the last 2 years.
Select...
I have been diagnosed with secondary osteoarthritis or inflammatory arthritis.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ up to 20 months
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~up to 20 months
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
Target Gene Expressions in Osteoarthritic Knee Cartilage after 6 Months of Supplementation
Secondary study objectives
Knee
SF-36 to Measure Changes in Physical and Mental Function between baseline and at 12 Months Post-surgery
SF-36 to Measure Changes in Physical and Mental Function between baseline and at 6 Months
+4 moreAwards & Highlights
No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.
Trial Design
2Treatment groups
Experimental Treatment
Active Control
Group I: ArginineExperimental Treatment1 Intervention
L-arginine 1.5 g capsule by mouth, once daily for 6 months
Group II: No InterventionActive Control1 Intervention
no supplement for 6 months
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
L-arginine
2016
Completed Phase 4
~1380
Find a Location
Who is running the clinical trial?
Memorial University of NewfoundlandLead Sponsor
71 Previous Clinical Trials
1,835,951 Total Patients Enrolled
2 Trials studying Osteoarthritis
330 Patients Enrolled for Osteoarthritis
Ocean Frontier InstituteUNKNOWN
Guangju Zhai, PhDPrincipal InvestigatorMemorial University of Newfoundland
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- I have received treatments like viscosupplementation or PRP injections.I have had a fracture due to weak bones or knee surgery in the last 6 months.I haven't taken arginine supplements in the last 6 months.I have used bisphosphonates in the last 2 years.I am scheduled for knee replacement surgery due to arthritis.I can walk on my own.I have been diagnosed with secondary osteoarthritis or inflammatory arthritis.
Research Study Groups:
This trial has the following groups:- Group 1: Arginine
- Group 2: No Intervention
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.